Registering A CAGR of 2.6%, Hepatitis B Therapeutic Drug Market (2015-2021) is Envisioned to Behold the Fastest Growth in The Coming 5-6 Years

Hepatitis B, a leading cause of human mortalities across the globe, is a fatal disease that leads to infections in the liver. A person suffering from Hepatitis B needs proper and intensive care which is provided through various therapeutic drugs of Hepatitis B available in the market. Global hepatitis B therapeutic drug market was valued at approximately USD 3.2 Billion in 2014 and is anticipated to foster at a modest compound annual growth rate (CAGR) of 2.6% over the forecast period i.e. 2015-2021. Geographically, the market is segmented into North…

Read More